Hitchhiking cancer vaccine makes progress in the clinic
Elicio Therapeutics is testing a pancreatic cancer vaccine using technology first developed at MIT in clinical trials, with promising Phase 1 results.
Source: mit.edu
Stay updated with breaking news from Demuth Phd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Elicio Therapeutics is testing a pancreatic cancer vaccine using technology first developed at MIT in clinical trials, with promising Phase 1 results.